Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 17030302 | ML-264 | 1550008-55-3 | 98% |  |
| ML-264 is a Krppel-like factor 5 (KLF5) inhibitor That Potently Inhibits Growth of Co | ||||
| 17030109 | MK-8245 | 1030612-90-8 | 98% |  |
| MK-8245 is a potent, liver-targeted SCD inhibitor with preclinical antidiabetic and a | ||||
| 17030101 | MLN-1117 | 1268454-23-4 | 98% |  |
| Serabelisib (also known as MLN1117, INK1117, and TAK-117) is an orally bioavailable i | ||||
| 17022811 | ML-281 | 1404437-62-2 | 98% | |
| ML-281 is a potent ans selective STK33 inhibitor (IC50 = 14 nM). ML281 showed low nan | ||||
| 17022804 | Maraviroc | 376348-65-1 | 98% |  |
| Maraviroc (UK-427857; Selzentry; Celsentri) is a selective CCR5 antagonist (IC50= 6.4 | ||||
| 17022403 | MMAE (Monomethyl auristatin E) | 474645-27-7 | 98% | -cas-474645-27-7.png) |
| MMAE, also known as Monomethyl auristatin E, is a synthetic antineoplastic agent. Bec | ||||
| 17021322 | Monastrol | 329689-23-8 | 98% |  |
| Monastrol is a cell-permeable small molecule inhibitor of kinesin-5(KIF11) which is | ||||
| 17021313 | MS049 | 1502816-23-0 | 98% | |
| MS049 is a potent and selective inhibitor of PRMT4 and PRMT6 with IC50s of 34 nM | ||||
| 17021301 | Miransertib(ARQ 092) | 1313883-00-9 | 98% | -cas-1313883-00-9.png) |
| ARQ 092 is a novel, orally bioavailable and selective AKT pathway inhibitor exhibit | ||||
| 712101 | MT-DADMe-ImmA(MTDIA HCl) | 1399840-35-7 | 98% | -cas-1399840-35-7.png) |
| Methylthio-DADMe-immucillin-A (MT-DADMe-ImmA) is an 86-pm inhibitor of human 5-methyl | ||||
| 17011908 | 7-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-aMine | 7752-54-7 | 98% |  |
| 7-Methyl-7H-pyrrolo[2,3-d]pyriMidin-4-aMine | ||||
| 17011107 | ML-7 | 110448-33-4 | 98% |  |
| ML-7 is an inhibitor of smooth muscle myosin light chain kinase (MLCK) with a Ki | ||||
| 17011105 | MX69 | 1005264-47-0 | 98% | |
| MX69 is a MDM2/XIAP inhibitor, used for cancer treatment. | ||||
| 16123055 | MK-571 sodium salt | 115104-28-4 | 98% |  |
| MK-571 is a selective, orally active CysLT1 receptor antagonist. It blocks the bindin | ||||
| 16123053 | Mizoribine | 50924-49-7 | 98% |  |
| Mizoribine,Mizoribine (INN, trade name Bredinin) is an immunosuppressive drug. The co | ||||
| 16123052 | Mivebresib | 1445993-26-9 | 98% |  |
| Mivebresib, also known as ABBV-075, is a potent BET inhibitor (bromodomain (BRD)-cont | ||||
| 16123051 | Mitoxantrone HCl | 65271-80-9 | 98% |  |
| Mitoxantrone hydrochloride is the hydrochloride salt of an anthracenedione antibiotic | ||||
| 16123049 | Mirin | 1198097-97-0 | 98% |  |
| Mirin is a Mre11-Rad50-Nbs1 (MRN)-ATM pathway inhibitor. | ||||
| 16123048 | Migalastat HCl | 75172-81-5 | 98% |  |
| Migalastat HCl, also known as AT1001 or GR181413A, is a pharmacological chaperone tha | ||||
| 16123047 | MI-2 (MALT1 inhibitor) | 1047953-91-2 | 98% | |
| MI-2 is a MALT1 inhibitor (IC50 = 5.84 M). MI-2 binds directly to MALT1 and irreversi | ||||
| 16123046 | MG-101 | 110044-82-1 | 98% |  |
| MG-101, also known as Calpain Inhibitor I and ALLN, is a calpain inhibitor (IC50 = 0. | ||||
| 16123045 | Mertansine (DM1) | 139504-50-0 | 98% | |
| Mertansine refers to the thiol-containing maytansinoid, DM1 (N2-deacetyl-N2-(3-mercap | ||||
| 16122832 | MC-976 | 129831-99-8 | 98% | |
| MC-976 is an Vitamin D3 derivative. | ||||
| 16122831 | Mafodotin | 863971-19-1 | 98% | |
| Mafodotin, also known as mc-MMAF and SGD-1269 or Maleimidocaproyl monomethylauristati | ||||
| 16122830 | Madrasin | 374913-63-0 | 98% | |
| Madrasin is a potent and cell penetrant splicing inhibitor that interferes with the e | ||||
| 16122829 | M2I-1 | 312271-03-7 | 98% | |
| M2I-1, also known as Mad2 Inhibitor-1, is Protein-Protein Interaction Inhibitor Targe | ||||
| 161227105 | MK571 | 115103-85-0 | 98% | |
| MK-571 is a selective, orally active CysLT1 receptor(Cysteinyl leukotriene receptor) | ||||
| 16122796 | MPTP hydrochloride | 23007-85-4 | 98% |  |
| MPTP hydrochloride is a dopaminergic neurotoxin and cause selective destruction of do | ||||
| 16122790 | ML323 | 1572414-83-5 | 98% | |
| ML323 is a highly potent and selective USP1-UAF1 inhibitor with IC50 of 76 nM.ML323 i | ||||
| 16122749 | ML390 | 2029049-79-2 | 98% |  |
| ML390 is a human DHODH inhibitor that induces differentiation in acute myeloid leukem | ||||